23.33 - 26.345
19.82 - 86.3
Join Discuss about CYRX with like-minded investors
Next Dividend Date
Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through its family of companies, Cryoport Systems, MVE Biological Solutions, CRYOPDP and Cryogene, Cryoport provides strategic solutions that will support the growing needs of these markets. The Company mission is to support life and health on earth through our advanced technologies, global supply chain network and dedicated scientists, technicians and supporting teams of professionals. Cryoport serves clients in life sciences research, clinical trials, and product commercialization. The Company supports the creation of life, the sustaining of life and life-saving advanced cell and gene therapies in over 100 countries around the world.